 Wysłany: Wto 13:55, 22 Mar 2011 Temat postu: mbt zapatos Hypothermia treatment efficacy of seve |
|
| Hypothermia treatment efficacy of severe head injury
trichWD,Tory Burch outlet, BustoR, HaeyM, eta1. TheimportanceofbraintemperatureinatterationsoftheMoodbrrin-barrierfollowingcerebra1. JNeuropathExpNeuvol, 199049:4864 LyethBG, JiangJY, RohertsonSE, etalHypathermiabluntsacetylcholineincreaselnCSFoftraumatieatlvbrajninjuredratesMoLchemNeuropath, l993, 182725ShiozaklT, SugimotoH, TanedaM. etatEfee (0fmildhypothermaonuncontro [1abileintracrania】 bypertensonaftersevereheadinjuryJNeurosurg, 1993,79:3636 MarionDW, Obr [stWD,MBT footwear, CarlterPMeta1.TheuseotmoderatehypotherniaforPatientswithsevereneadin-Juries: aPreliminaryreportJNeurosurg, 1993,79:354 t,, cents:. Shuxuening injection in the treatment of 47 cases of ischemic cerebrovascular disease effects Lin observed Mexican Coke (the First Affiliated Hospital of Guangxi Medical University, Neikenanning 530021) from October 1997 to December 1998 our department used Shuxuening injection on 47 patients with acute ischemic cerebrovascular disease treatment down to low molecular weight dextran treatment of 16 patients with acute ischemic cerebrovascular disease as controls, before and after treatment for neurological deficit score, blood examination. plasma fibrinogen levels and blood lipid test results reported as follows t now. l 1.1 Materials and Methods Clinical data: The treatment group of 47 down, down male 38, female 9, aged 41 to 83-year-old male control group, 13 cases of 16 patients with t and 3 women down, aged 43 to 78 years old. the two groups in all cases the brain by the Second National disease diagnostic criteria adopted by the meeting of a clear diagnosis of acute ischemic cerebrovascular disease and confirmed by brain CT scan. neurological impairment of stroke patients according to clinical neurologic impairment score standard treatment group and control group of patients were within 1 ~ sd after the onset of the beginning into the study. the treatment group Shuxuening injection 200ml (containing Ginkgo biloba extract 100mg · Hospital of Guangxi Medical University,mbt scarpe italia, Department of Pharmacy, a tarsal production) intravenously, 1 King every day, once a 14d. control group with low molecular weight dextran 500mI, intravenous t 1 a day, once every 14d. In addition to lowering brain pressure during the observation period, blood pressure Franc Cypriot music, antibiotics,mbt zapatos, the other on the blood rheology, drugs that affect blood circulation, thrombolytic anticoagulant, lipid-lowering drugs is prohibited. both groups before treatment and after 1 ~ 2d, requested the inspection morning fasting venous blood rheology, plasma fibrinogen * scholars, Received I1 Binyang County People's Hospital of: I999 a O1 a z07 {a fibrinogen content of blood lipids. by LBY ~ 7-type blood viscometer intelligent variable indexes of blood glistening set t 13-7170A automatic analyzer fibrinogen and blood lipids. treatment, the clinical data and test results x defense test and f test. 13 efficacy assessment: According to 100; significant progress: neurologic deficit score by 48% to 89; progress: reduced neurological deficit scores l8 ~ 45; No change: neurological deficit scores increase or decrease within 18; worse: defect score increase in 18 or more. 2 results of the clinical data before and after treatment in both groups 2-1 in Table 1. Table 1 Clinical data comparing the two groups before and after treatment () groups before treatment of the question, age, neurological impairment score was no significant difference (P> O05), a comparable sex. to reduce neurologic impairment after treatment scores was significant difference (P <0.01) clinical efficacy: The treatment group of 47 down in the base l good recovery in 14 cases (29-T9), l6 cases significant progress, progress l1 cases. Total efficient More articles related to topics： ralph lauren sale Uvulopalatopharyngoplasty in the Mycoplasma , chlamydia infection and spontaneous abortion _4058 Discussion polo shirts Mycoplasma pneumoniae disease in child |
|
